The new long-acting growth hormone TransCon hGH is in Phase 3 clinical application in the United States.
-
Last Update: 2020-07-19
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Original source: Ascendis Pharma A/S Announcs Submission s on Biologics License Application (BLA) to FDA for TransCon™ hGH in Pediatric Growth Eron OnoyOriginal Title: New Drugs for Child Growth Hormone Deficiency! New long-acting growth hormone TransCon hGH in the United States application for listing, China is in Phase III clinical!
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
